The objective of this Professional Oncology Educational Program is to continue and to augment our ongoing comprehensive multidisciplinary educational program in oncology. Our ultimate aim is to produce graduate physicians who are well trained in the integrated approach to the patient with cancer. In addition, the education of nurses, paramedical personnel, lay persons, and practicing physicians in within the scope of this educational program. A basic core and elective curriculum in cancer has been created for the first two yeara of medical school, a successful summer clinical assistant program for medical students is well established, and strong clinical specialties exist in all of the major clinical disciplines to provide for the education of clinical assistants, third and fourth year medical students, and post-graduate physicians. These programs will be continued, with the creation of a new clinical elective in Surgical Oncology and an elective on Research Methodology/New Approaches to Cancer which will initially be integrated into our summer student program. Additionally, the educational program will expand to include activities which exist at Vanderbilt but which are not fully integrated into the present cancer education activities. Specifically, programs in epideomilogy, nutrition, patient attitudes/prevention, early detection of cancer, medical ethics will be added to the educational program through a series of planned symposia and electives as well as by inclusion of these disciplines in present courses (i.e. clinical cancer course, summer student program). Furthermore, with the addition of a clinical nurse specialist in oncology, and the designation of a special in-patient unit at Venderbilt University Hospital as an Oncology Unit, we are ready to embark on an extensive program in oncology nursing education, a program which will involve not only nurses at Vanderbilt but in the community.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Education Projects (R25)
Project #
5R25CA019429-11
Application #
3451730
Study Section
Clinical Cancer Education Committee (CEC)
Project Start
1976-07-01
Project End
1988-06-30
Budget Start
1986-07-01
Budget End
1988-06-30
Support Year
11
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37203
Halter, S A; Fraker, L D; Parl, F et al. (1990) Selective isolation of human breast carcinoma cells resistant to the growth-inhibitory effects of retinol. Nutr Cancer 14:43-56
Stein, R S; Albridge, K; Lenox, R K et al. (1988) Nephrotoxicity in leukemic patients receiving empirical amphotericin B and aminoglycosides. South Med J 81:1095-9
Halter, S A; Fraker, L D; Adcock, D et al. (1988) Effect of retinoids on xenotransplanted human mammary carcinoma cells in athymic mice. Cancer Res 48:3733-6
Hainsworth, J D; Dial, T W; Greco, F A (1988) Curative combination chemotherapy for patients with advanced poorly differentiated carcinoma of unknown primary site. Am J Clin Oncol 11:138-45
Robinson Jr, W E; Mitchell, W M; Chambers, W H et al. (1988) Natural killer cell infection and inactivation in vitro by the human immunodeficiency virus. Hum Pathol 19:535-40
Johnson, D H; DeLeo, M J; Hande, K R et al. (1987) High-dose induction chemotherapy with cyclophosphamide, etoposide, and cisplatin for extensive-stage small-cell lung cancer. J Clin Oncol 5:703-9
Griffin, D; Said, H M (1987) The enterohepatic circulation of methotrexate in vivo: inhibition by bile salt. Cancer Chemother Pharmacol 19:40-1
Ellis, D L; Kafka, S P; Chow, J C et al. (1987) Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trelat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes. N Engl J Med 317:1582-7
Hainsworth, J D; Greco, F A (1987) Unrecognized leukemia cutis. South Med J 80:663-4
Gates, R E; Mayfield, C; Allred, L E (1987) Human neonatal keratinocytes have very high levels of cellular vitamin A-binding proteins. J Invest Dermatol 88:37-41

Showing the most recent 10 out of 33 publications